By Alaric Dearment, Med City News | September 26, 2019 A panel discussion at the DTx East conference in Boston discussed whether partnerships between digital health and drugmakers were "a match made in heaven." With digital therapeutics becoming a growing component of the medical care ecosystem, it’s only natural that [...]
By Greg Licholai, Contributor, Forbes | August 13, 2019 This is an exciting summer for the Digital Therapy (DTX) industry. Recently Voluntis announced marketing authorizationof the first oncology disease management software platform. This comes on the heels of two impressive IPOs for digital health companies Livongo and Health Catalyst. Livingo [...]
By Rob Wright, Life Science Leader | May 31, 2019 $1.7 billion. That was the entire digital therapeutics market in 2017. While that’s a little more than most people have in the bank, it’s still a fairly small number for most Big Pharmas. But that market is projected to grow [...]
